CCL13 antibody (C-Term)
Quick Overview for CCL13 antibody (C-Term) (ABIN6736685)
Target
See all CCL13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human CCL13 / MCP4
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human CCL13 (Q99616, NP_005399). Percent identity by BLAST analysis: Human, Chimpanzee (100%), Gorilla, Gibbon (93%), Monkey (86%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: WB (0.2 - 1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- CCL13 (Chemokine (C-C Motif) Ligand 13 (CCL13))
-
Alternative Name
- CCL13 / MCP-4
-
Background
-
Name/Gene ID: CCL13
Family: Intercrine
Synonyms: CCL13, C-C motif chemokine 13, CKb10, MCP-4, MCP4, Monocyte chemotactic protein 4, New CC chemokine 1, Small-inducible cytokine A13, NCC1, CK-beta-10, NCC-1, SCYA13 -
Gene ID
- 6357
-
NCBI Accession
- NP_005399
-
UniProt
- Q99616
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Target
-